ONC stock Statistics — BeOne Medicines Ltd. filings, insiders & smart money

Price chart (1D to 10Y)

Licensed market data — shown to members, not published to the open web.

Beta: Sign in
Shares outstanding: —
Shares float: Sign in
Float %: Sign in
Insider ownership: —
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 0.10%
Short ratioDays to cover, as published by FINRA: 4.16
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 67.00%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 68.90%
Avg volume (10D): Sign in

Source: SEC filings. Information and analytics, not investment advice.

Avg volume (3 months)

Gross marginTTM to Jun 26: 88.89%
Operating marginTTM to Jun 26: 15.06%
Net margin: —
EBITDA marginFY Dec 25: 11.02%
Return on equityNet income (TTM to Jun 26) ÷ average shareholders equity: 14.66%
Return on assetsNet income (TTM to Jun 26) ÷ average total assets: 8.47%

Cash & equivalentsas of Jun 26: $5.09B
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Jun 26: $1.07B
Debt / equityas of Jun 26: 20.74%
Current ratioas of Jun 26: 3.40
Quick ratio: —
Operating cash flowTTM to Mar 26: $1.28B
Free cash flowUnadjusted FCF = CFO − capex · TTM to Mar 26: $1.11B
TTM revenue / diluted shareDiluted, TTM to Jun 26: 4.09